Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramucirumab + Trastuzumab + Paclitaxel in HER2+ Gastric Cancer
NCT04888663Phase 2Unknown
- Sponsor
- Yonsei University
- Start
- Feb 2018
- Primary completion
- Sep 2021
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab in gastric cancer (GC), sponsored by Yonsei University. Status: unknown.
02
Drugs
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT04888663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04888663.